🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
This phase I/II trial studies the side effects of gene-modified immune cell...
Status
Terminated
Location
Fred Hutch/University of Washington Cancer Consortium
Start Date
2019-07-03
Trial ID
NCT03747484
This is a Phase I dose escalation trial to assess MTD of MK-3475 in combina...
Status
Terminated
Location
Huntsman Cancer Institute
Start Date
2015-01-23
Trial ID
NCT02268825
Treatments Being Tested
This is a Phase Ib/II, open-label, single institution dose-escalation, safe...
Status
Terminated
Location
University of Texas Health Science Center at San Antonio
Start Date
2024-12-27
Trial ID
NCT06516887
Treatments Being Tested
The main goals are after treatment given before surgery, to measure the num...
Status
Recruiting
Location
Southern Cancer Center (SCC) ( Site 8004)
Start Date
2025-03-20
Trial ID
NCT06788912
This phase II study is designed to determine the clinical efficacy of PD-1 ...
Status
Recruiting
Location
National Research Oncology Center
Start Date
2024-01-09
Trial ID
NCT06812858
Treatments Being Tested
Immune therapies work with the body's immune system to treat a number of ca...
Status
Terminated
Location
Providence Medical Foundation
Start Date
2021-10-19
Trial ID
NCT05083481
This research study is studying if the investigational drug, Pembrolizumab,...
Status
Recruiting
Location
Brigham and Women's Hospital
Start Date
2024-10-18
Trial ID
NCT06475235
Treatments Being Tested
Phase 1b open-label study to evaluate the safety of selected TIL (TBio-4101...
Status
Active Not Recruiting
Location
Moffitt Cancer Center
Start Date
2024-03-14
Trial ID
NCT06236425
Treatments Being Tested
This phase II trial compares the effect of GI-102 alone and in combination ...
Status
Recruiting
Location
Mayo Clinic in Rochester
Start Date
2026-04-01
Trial ID
NCT07301268
This phase III trial compares the effect of adding cetuximab to pembrolizum...
Status
Recruiting
Location
University of Arkansas for Medical Sciences
Start Date
2025-03-27
Trial ID
NCT06589804